Garry Menzel

CEO of TCR2 Therapeutics & Tcr2 Therapeutics Inc.

Contact

Companies

Company

Roles

Tcr2 Therapeutics Inc.

Tcr2 Therapeutics Inc. is a Cambridge, Massachusetts-based company founded in 2015.

CEO

TCR2 Therapeutics

TCR2 Therapeutics is a biotechnology company developing T cell hematologic cancer immunotherapies.

CEO

Board Member

Stoke Therapeutics

Stoke Therapeutics is a biopharma company that develops RNA-targeted treatments for severe genetic diseases.

Board Member